*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>DM-1 (Dolastatin 10 derivative) is a potent cytotoxic agent serving as the payload for antibody-drug conjugates (ADCs). Synthesized via solid-phase peptide synthesis, its core structure features a unique valine-valine-amide linkage. <strong>Molecular Formula</strong>: C<sub>26</sub>H<sub>40</sub>N<sub>6</sub>O<sub>5</sub>; <strong>CAS No.</strong>: 179837-77-1.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Research</strong>: Utilized in developing ADCs targeting CD30 and other tumor-associated antigens.</li>
<li><strong>Pharmaceutical Manufacturing</strong>: Sourced as a high-purity intermediate for clinical trial drug production.</li>
<li><strong>Bioconjugation Studies</strong>: Employed in linker chemistry optimization for targeted therapy delivery systems.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly limited to research use; not approved for standalone clinical administration. Requires storage at -20°C under inert atmosphere. Personnel must utilize PPE due to extreme potency and potential neurotoxicity risks during handling.</p>